Showing results (381-390 of 402) with videos related to

Sort By:
Pageof 41
Nature Communications|July 8, 2025
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse modelsJoan Kyula-Currie, Victoria Roulstone, James Wright, et al.
Molecular Cell|January 2, 2019
RIPK1 and Caspase-8 Ensure Chromosome Stability Independently of Their Role in Cell Death and InflammationGianmaria Liccardi, Laura Ramos Garcia, Tencho Tenev, et al.
Clinical Cardiology|May 21, 2015
Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study designHeerajnarain Bulluck, Georg M Fröhlich, Shah Mohdnazri, et al.
BMC Nephrology|December 12, 2018
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trialNasser A Dhayat, Nicolas Faller, Olivier Bonny, et al.
The New England Journal of Medicine|March 1, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceNasser A Dhayat, Olivier Bonny, Beat Roth, et al.
Nature Medicine|November 8, 2016
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancerFara Brasó-Maristany, Simone Filosto, Steven Catchpole, et al.
Science Advances|July 26, 2023
Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repairKristel Martinez Lagunas, Deniz Pinar Savcigil, Matea Zrilic, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 30, 2026
Updating national diagnostic reference levels for adult cardiac interventional procedures in SwitzerlandEleni Theano Samara, Jonas Ekeberg, Gustavo S P Pamplona, et al.
Circulation|June 15, 2026
Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority TrialChristian Spaulding, Florian Krackhardt, Kris Bogaerts, et al.
Nature Communications|May 24, 2025
Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasionVictoria Roulstone, Joan Kyula-Currie, James Wright, et al.
Pageof 41